Note: This article is the first in a series.
January 8, 2015—A little over nine years ago, Congress wanted to know why health care providers had no way to tell whether they were being overcharged for 340B discounted drugs.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)